PointState Capital’s CVS Health CVS Stock Holding History

PointState Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-150,000	Closed	-$11.3M	–	142
2021 Q1	$11.3M	Buy	+150,000	New	+$10.9M	0.22%	75
2019 Q2	–	Sell	-50,000	Closed	-$2.7M	–	121
2019 Q1	$2.7M	Buy	+50,000	New	+$3.09M	0.05%	90
2018 Q4	–	Sell	-50,000	Closed	-$3.94M	–	101
2018 Q3	$3.94M	Buy	50,000 +25,000	+100%	+$1.79M	0.05%	99
2018 Q2	$1.61M	Buy	+25,000	New	+$1.65M	0.02%	144

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PointState Capital's CVS Position: Q1 2022 in Review

PointState Capital sold out of CVS Health (CVS) in Q1 2022, closing a stake of 172,500 shares — an estimated $17.8M sold.

PointState Capital first reported a position in CVS in Q3 2018 and held it in 7 quarters. The position peaked at $31.6M in Q3 2018. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

PointState Capital reported no remaining CVS Health position as of Q1 2022 after selling out during the quarter.
PointState Capital sold 172,500 CVS Health shares in Q1 2022, an estimated $17.8M.
PointState Capital first reported a position in CVS Health in Q3 2018 and held it in 7 quarters.
PointState Capital's CVS Health position peaked at $31.6M in Q3 2018.
2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on PointState Capital's 13F filing for Q1 2022, filed 13 May 2022.